DGCR8 and myelodysplastic syndrome: Taken together, the progressive increase in DGCR8 expression in high-risk MDS may reflect an adaptive response that enables malignant progenitor cells to maintain minimal miRNA-processing capacity, supporting clonal persistence despite upstream processing defects.